Latest Announcements

BSE & NSE corporate filings with AI summaries

NSECopy of Newspaper PublicationResults4d ago

Torrent Pharmaceuticals Limited

Copy of Newspaper Publication

Torrent Pharmaceuticals Limited has informed the Exchange about the completion of dispatch of Postal Ballot Notice through electronic mode to its members whose email IDs are registered with the company/depositories as on July 31, 2026.

Read more →📎 1 attachment
NSECopy of Newspaper PublicationRegulatory4d ago

Aegis Logistics Limited

Copy of Newspaper Publication

Aegis Logistics Limited has informed the Exchange about a special window for transfer and dematerialisation of physical securities, as per SEBI's Circular No. SEBVHO/MIRSD/MIRSDPoDy dated July 2, 2025, and Circular No. HO/38/13/11(2) 2026-MIRSD-POD/1/3750/2026 dated January 30, 2026.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults4d ago

Deepak Fertilisers & Petrochemicals Corporation Ltd

Management Transcript of Q1 FY 2027 Earnings Conference Call

Deepak Fertilisers & Petrochemicals Corporation Ltd's Q1 FY 2027 earnings conference call transcript is available on the company's website, with management discussing a 65% jump in operating EBITDA and doubling of PAT, despite volatility from the Middle East war. The company's integrated value chain and alignment with India's growth story are highlighted as key strengths.

Read more →📎 1 attachment
BSECompany Update▲ PositiveFundraise4d ago

Edelweiss Financial Services Ltd

Business Update in US dollar

Edelweiss Financial Services Ltd has released a business update on EAAA Alternatives, a subsidiary, highlighting a large and scalable opportunity in the Indian Alternatives market. The update projects a 2.6x surge in Alternatives AUM from $276 billion in 2016 to $211 billion by 2030, with a dominant share of over 50% of the entire Indian Alts market. The update also emphasizes the growing pool of domestic investors, with HNIs and UHNIs projected to grow at 9.6% and 15.8% CAGR respectively by 2027.

Read more →📎 1 attachment
NSEChange in ManagementMgmt Change4d ago

Emcure Pharmaceuticals Limited

Change in Management

Emcure Pharmaceuticals Limited has informed the Exchange about change in Management. Mr. Berjis Desai has expressed his unwillingness to seek re-appointment as Chairman and Non-executive, Non-Independent Director, and will cease to hold office from the conclusion of the ensuing AGM. Mr. Raghu Kumar has been appointed as an Additional Director (Non-Executive and Independent) and Mr. Satish Mehta has been appointed as the Chairman of the Company.

Read more →📎 1 attachment
BSEBoard MeetingResults4d ago

Mold-Tek Technologies Ltd

Outcome of the Board Meeting

Mold-Tek Technologies Ltd has announced its un-audited financial results for the first quarter ended June 30, 2026, with revenue from operations at ₹4,551.93 lakhs and total income at ₹4,796.29 lakhs. The company's expenses include employee benefits expense of ₹2,605.79 lakhs, finance costs of ₹9.78 lakhs, and depreciation and amortisation expenses of ₹134.65 lakhs.

Read more →📎 1 attachment
BSECompany Update▲ PositiveExpansion4d ago

Edelweiss Financial Services Ltd

Business Updates

Edelweiss Financial Services Ltd announced a business update on EAAA Alternatives, a subsidiary of the company, highlighting the opportunities in the Indian Alternatives market, with a projected AUM of $211 bn by 2030 and a CAGR of 18%.

Read more →📎 1 attachment
BSECompany UpdateMgmt Change4d ago

Emcure Pharmaceuticals Ltd

Intimation under Regulation 30 of the SEBI (LODR) Regulations, 2015 - Change in composition of the Board of the Company

Emcure Pharmaceuticals Ltd has announced changes in its Board of Directors, with Mr. Berjis Desai resigning as Chairman and Non-Executive Director, and Mr. Raghu Kumar being appointed as an Additional Director. Mr. Satish Mehta will take over as Chairman of the Company. The changes are effective from the conclusion of the ensuing Annual General Meeting.

Read more →📎 1 attachment
NSEOutcome of Board MeetingFundraise4d ago

Nazara Technologies Limited

Outcome of Board Meeting

Nazara Technologies Limited has informed the exchange about the outcome of its board meeting, where it approved the issuance of up to 2,39,70,676 equity shares at ₹306 per share, aggregating up to ₹7,33,50,26,856, on a preferential basis, to identified investors. The company also approved an increase in its authorized share capital from ₹80,00,00,000 to ₹90,00,00,000 and the convening of an EGM to seek shareholder approvals.

Read more →📎 1 attachment
BSEBoard MeetingFundraise4d ago

Nazara Technologies Ltd

Nazara Technologies Limited informs the Exchange regarding Outcome of Board Meeting held on August 06, 2026.

Nazara Technologies Ltd has informed the exchange about the outcome of its board meeting held on August 06, 2026, where it approved the issuance of up to 2,39,70,676 equity shares at ₹306 per share, aggregating up to ₹7,33,50,26,856, on a preferential basis, to identified investors, subject to shareholder approval and other regulatory approvals. The company also approved an increase in its authorized share capital from ₹80,00,00,000 to ₹90,00,00,000 and the convening of an EGM on August 30, 2026, to seek shareholder approvals.

Read more →📎 1 attachment
BSEAGM/EGMMgmt Change4d ago

Kanoria Chemicals & Industries Ltd

The Annual General Meeting shall be held on Wednesday, 2nd September 2026 at 11:00 A.M. through Video Conference ("VC")/Other Audio Visual Means ("OAVM)

Kanoria Chemicals & Industries Ltd has announced the 66th Annual General Meeting (AGM) to be held on September 2, 2026, through video conference. The meeting will consider the audited financial statements for the FY 2025-26, appointment of a director, and re-appointment of an independent director. The company will also consider ratifying the remuneration to cost auditors.

Read more →📎 1 attachment
← PreviousPage 551 of 2944Next →